Status:
COMPLETED
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
Lead Sponsor:
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
Conditions:
Allergic Sensitization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patch Testing for device cream on human subjects
Eligibility Criteria
Inclusion
- Male or Female
- 18+ years
- Good health
- Signed and datad Informed Consent
- Signed and dated HIPAA
Exclusion
- On test at any other research lab or clinic
- Known allergy or sensitivity to cosmetics or toiletries
- Pre-existing other medical conditions
- Treatment with antibiotics, antihistamines, or corticosteroids within 2 weeks of the test
- Chronic medication which could affect the outcome of the study
- Known pregnant or nursing women
- Cancer diagnosis within the past 5 years
Key Trial Info
Start Date :
November 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2017
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT03450070
Start Date
November 15 2017
End Date
December 22 2017
Last Update
May 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harrison Research Laboratories
Union, New Jersey, United States, 07083